About Valencia Technologies
Valencia Technologies is a Healthcare company based in Santa Clarita (United States) founded in 2011 by Jeff Greiner, and was acquired by Boston Scientific in January 2026. A coin-sized neuromodulation device for hypertension treatment is developed. Valencia Technologies has raised $54.97 million across 9 funding rounds from investors including Boston Scientific and BMG. Its focus areas include Life Sciences, Genitourinary Disorders, Medical Devices and Therapeutics. Its legal entity is VALENCIA TECHNOLOGIES CORPORATION. Its competitors include Amphora Medical, EMKinetics and Cogentix Medical; 3 of its 3 listed competitors have raised funding.
Company details
Valencia Technologies was founded in 2011 and is based in Santa Clarita, United States. A subcutaneous neuromodulation system, resembling a coin-sized pacemaker, is developed by the company for hypertension management. The technology targets nerve modulation and holds potential for applications in pain relief, depression, Parkinsons disease, and obesity treatments within the medical device sector. Operations focus on device innovation and clinical development.
- Headquarters Santa Clarita, United States
- Founders Jeff Greiner
- Stage Acquired
- SectorsHealthcare
- Website valenciatechnologies.com
- Social LinkedIn X Facebook
- Acquired by Boston Scientific (Jan 2026)
- Legal Name Valencia Technologies Corporation
- Total Equity Funding$54.97M (USD)
in 9 rounds
- Latest Funding Round$35M (USD), Series B
Feb 2025
- InvestorsBoston Scientific
& 1 more
- Acquired byBoston Scientific
(Jan 2026)
Funding Insights of Valencia Technologies
Valencia Technologies has successfully raised a total of $54.97M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $35 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $54.97M
- Total Rounds 9
- Last Round Series B — $35M
- First Round $2.75M
(May 2013)
- Investors Count 1
All 9 funding rounds of Valencia Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2025 | $35M | Series B | – | BMG | – |
| Mar 2020 | $4.16M | Series A | – | – | – |
| Jan 2019 | $1.54M | Series A | – | – | – |
| Aug 2018 | $2.4M | Series A | – | – | – |
| Mar 2017 | $1.9M | Series A | – | – | – |
| Jan 2016 | $2.36M | Series A | – | – | – |
| Mar 2015 | $2.22M | Series A | – | – | – |
| Oct 2013 | $2.66M | Series A | – | – | – |
| May 2013 | $2.75M | Series A | – | – | – |
2 investors in total: 2 institutional.
Investors in Valencia Technologies
Valencia Technologies has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific and BMG.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| brooksmgtgroup.com | ||||
Wide range of medical devices | 1979 | bostonscientific.com | Marlborough, United States |
Investor details for Valencia Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Valencia Technologies
24 people are tracked at Valencia Technologies (6 in leadership, 18 in team).
| Name | Role | Group |
|---|---|---|
Jeff Greiner | Founder | Leadership |
Alexandra Rogers | VP of Physician Training | Leadership |
Dave Peterson | Chief Technology Officer | Leadership |
Russ Ramanayake | VP of Finance | Leadership |
Chula Thenuwara | Chief Of Mechanical And Materials Engineering | Leadership |
Tom Patzelt | Vice President Marketing | Leadership |
Chris Briggs | Senior Quality Engineer | Team |
Eduardo Ramirez | Sr. R&d Technician | Team |
Jose Galindo | Senior Manufacturing Engineer | Team |
King Chee | Sr. Distribution Specialist | Team |
Lin Li | Sr. Manufacturing Engineer | Team |
Aieamaxil Lorin | Manager, Professional Education & Procedural Training | Team |
Bryan McDaniel | Manager Of Professional Education And Procedural Training | Team |
Andrea Bergman | Quality Assurance Manager | Team |
João Yanez | Senior Quality Engineer | Team |
Charly Olenych | Executive Territory Manager | Team |
Shawn Stern | Executive Territory Manager - Valencia Technologies - Ecoin | Team |
Amber MacDonald | Senior Manager, Customer Service | Team |
Anne-Marie Northrup | Marketing Specialist & Project Manager | Team |
Erin Gwaltney | Manager Of Field Engineering, East | Team |
4 more people are available in the full profile.
Complete people profiles for Valencia Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Valencia Technologies
4 dated milestones of Valencia Technologies across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Valencia Technologies is founded.
- Funding First funding round of $2.8M.
- Funding Latest funding round, Series B, of $35.0M.
- Exit Acquired by Boston Scientific.
Competitors of Valencia Technologies
Valencia Technologies has 3 listed competitors in our database, 3 of them funded. They include Amphora Medical, EMKinetics and Cogentix Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amphoramedical.com | 2011 | Minneapolis, United States | $48.28M | 12 | Radiofrequency ablation device for overactive bladder treatment | |
| emkinetics.com | 2006 | San Francisco, United States | $12.53M | Transdermal stimulation therapy is provided for urinary incontinence treatment. | ||
| cogentixmedical.com | 1987 | Orangeburg, United States | $25M | 141 | Minimally invasive treatment of voiding dysfunctions and endoscopy solution |
Detailed competitors of Valencia Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Valencia Technologies
The website of Valencia Technologies (valenciatechnologies.com) receives about 3.6K visits a month.
- Monthly visits3.6K
▲ 91.6% vs previous month
Websites whose visitors overlap most with Valencia Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details |
Top companies in Genitourinary Disorders
3 companies that operate in the same segment as Valencia Technologies (Genitourinary Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction | 2012 | Malvern, Pennsylvania, United States | USD 104.6 M | USD 80.28 M | 209 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Valencia Technologies
Complete news archive for Valencia Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Valencia Technologies
Valencia Technologies was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Valencia Technologies is headquartered in Santa Clarita, United States. It is registered at Santa Clarita, California, United States.
Valencia Technologies is a funded company, having raised a total of $54.97M across 9 funding rounds to date. The company's 1st funding round was a Series A of $2.75M, raised on May 2013.
Valencia Technologies was founded in 2011 and is based in Santa Clarita, United States. A subcutaneous neuromodulation system, resembling a coin-sized pacemaker, is developed by the company for hypertension management. The technology targets nerve modulation and holds potential for applications in pain relief, depression, Parkinsons disease, and obesity treatments within the medical device sector. Operations focus on device innovation and clinical development.
Valencia Technologies's top competitors include Amphora Medical, EMKinetics and Cogentix Medical.
Valencia Technologies has 2 investors. Key investors include Boston Scientific, and BMG.
Valencia Technologies operates through Valencia Technologies Corporation.
Yes. Valencia Technologies was acquired by Boston Scientific in January 2026.